![](https://d3ilqtpdwi981i.cloudfront.net/qLxv1BgxSxI0HBe9t4qum_V1FVk=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/5b/13/26/5b13267a-586e-4084-b300-2f4b49142e11/thumbnail_85f40c9a-5d49-4843-872a-f7865897e875.jpg)
Article
Brief Report: The Impact of Disease Stage on Early Gaps in ART in the "treatment for All" Era - A Multisite Cohort Study.
Journal of Acquired Immune Deficiency Syndromes (1999)
Document Type
Article
Publication Date
12-17-2020
Subjects
- Real-time monitoring
Disciplines
Abstract
Adoption of "Treat All" policies has increased ART initiation in sub-Saharan Africa; however, unexplained early losses continue to occur. More information is needed to understand why treatment discontinuation continues at this vulnerable stage in care.
Rights
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.
Locate the Document
DOI
10.1097/QAI.0000000000002605
Persistent Identifier
https://archives.pdx.edu/ds/psu/35346
Citation Information
Katz, I. T., Musinguzi, N., Bell, K., Cross, A., Bwana, M. B., Amanyire, G., Asiimwe, S., Orrell, C., Bangsberg, D. R., & Haberer, J. E. (2021). Brief Report: The Impact of Disease Stage on Early Gaps in ART in the “Treatment for All” Era—A Multisite Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 86(5), 562–567. https://doi.org/10.1097/qai.0000000000002605